Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0039483 (
giant cell arteritis
)
3,204
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To determine if the pattern of macrophage activation reflects differences in the pathogenesis and clinical presentation of
giant cell arteritis
and primary angiitis of the central nervous system, specimens of 10 patients with
giant cell arteritis
and five with primary angiitis of the central nervous system were immunohistochemically studied and the expression of the macrophage activation markers 27E10,
MRP14
, MRP8 and 25F9 was determined in the vasculitic infiltrates. Thus, a partly different expression pattern of macrophage activation markers in
giant cell arteritis
and primary angiitis of the central nervous system was observed. The group comparison revealed that
giant cell arteritis
cases had significantly higher numbers of acute activated
MRP14
-positive macrophages, whereas primary angiitis of the central nervous system is characterized by a tendency toward more MRP8-positive intermediate/late activated macrophages. Furthermore, in
giant cell arteritis
comparably fewer CD8-positive lymphocytes were observed. These observations suggest, that despite their histopathological similarities,
giant cell arteritis
and primary angiitis of the central nervous system appear to represent either distinct entities within the spectrum of granulomatous vasculitides or different stages of similar disease processes. Their discrete clinical presentation is reflected by different activation patterns of macrophages, which may characterize
giant cell arteritis
as a more acute process and primary angiitis of the central nervous system as a more advanced inflammatory process.
...
PMID:The activation pattern of macrophages in giant cell (temporal) arteritis and primary angiitis of the central nervous system. 2435 10